companydata.dkMammen BioProcess Support ApS: Financial statements 2025
CVR: 43983881
Mammen BioProcess Support ApS (CVR 43983881) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,500,623 and a net result of DKK 261,391 compared with DKK 436,464 the year before. That is a decrease of 8.3% compared with the year before. Equity amounted to DKK 307,855. The solvency ratio was 39.5%.
- Gross Profit
- 1,500,623 kr.
- Profit/Loss
- 261,391 kr.
- Equity
- 307,855 kr.
- Total Assets
- 779,332 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.5 mio. | 261 t. | 308 t. | 0 |
| 2024 | - | 1.6 mio. | 436 t. | 476 t. | 1 |
Find more companies like Mammen BioProcess Support ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout Mammen BioProcess Support ApS
Mammen BioProcess Support ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Max Løjtved Mammen. The company is owned by Max Mammen Holding ApS. In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. Equity amounted to DKK 670,757.